To Home Page of PHI website to PHI's Secure Shopping Cart
PHI's Education
About PHI Education Advocacy Research Networking to How to Donate to Membership Application

Post-Polio Health (ISSN 1066-5331)

Vol. 29, No. 4, Fall 2013

Shingles Vaccine Experience
among the Survivors of Polio

Frederick M. Maynard, Chair, PHI Medical Advisory Committee, Marquette, Michigan

Members of PHI concerned that polio survivors might have abnormalities of the immune system questioned whether taking the shingles vaccine would either increase the risk of complications or make it less effective. In early 2013 PHI distributed a six-question survey through its PHI Membership Memo, website ( and Facebook. The PHI Association Member Communiqué asked support groups to recruit survey takers who had had polio from their memberships.

By late April, 293 people completed the survey. Some 64% of respondents (186) had taken the shingles vaccine (Zostavax®). Only six of these respondents (3%) reported any problems as a result of taking the vaccine.


Back to contents of this issue ...
Past Issues, Listed by Topic
Past Issues, Listed by Volume and Date















Back to top